With concern already growing about a possible third wave of COVID-19 infections, the UK has cleared the use of a fourth vaccine from Johnson & Johnson's Janssen division.
GlaxoSmithKline's COVID-19 drive has advanced on two fronts, with the start of phase 3 trials of its Sanofi-partnered vaccine candidate as well as an FDA emergency approval for antibody sot
Belgium's Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson's one-shot COVID-19 vaccine, following the death of a woman from what appeared to be
Lawyers for the European Commission asked a court in Brussels today to fine AstraZeneca millions of euros for its "obvious" failure to meet the terms of its contract to supply COVID-1
Moderna's COVID-19 vaccine has joined the Pfizer/BioNTech jab in showing efficacy in younger patients in clinical trials, setting up an emergency use filing early next month.